Back Pain, Neck Pain
Conditions
Brief summary
A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders
Detailed description
This study aims to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture by collecting information on adverse reactions, efficacy assessment variables, and treatment methods from patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment.
Interventions
PROCEDUREUltrasound-guided pharmacopuncture treatment
Pharmacopuncture treatment using ultrasound-guidance
Sponsors
Jaseng Medical Foundation
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
1. Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria) 2. Outpatients scheduled for ultrasound-guided pharmacopuncture treatment 3. Individuals aged 19 years or older and under 70 years 4. Individuals who agree to participate in the clinical study and voluntarily sign the consent form
Exclusion criteria
1. Individuals who are unable to complete the consent form 2. Individuals who are deemed unsuitable for participation in the clinical study by the researcher
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adverse Event | Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups | Adverse events assessment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Spinal pain numeric rating scale | Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups | Spinal pain numeric rating scale |
| Disability index | Week 0, 2, 4, 8, 12 | Neck disability index or Oswestry Disability Index |
| EQ-5D-5L | Week 0, 2, 4, 8, 12 | Quality of life using EQ-5D-5L |
| Patient satisfaction | Week 4 | Patient satisfaction survey |
Countries
South Korea
Outcome results
None listed